Iroquois Capital Management, LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 10:15 am Purchase | 2025-03-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 5,939,954 9.990% | 5,838,871 (+5776.29%) | Filing |
| 2025-02-26 09:16 am Purchase | 2025-02-17 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 101,083 9.990% | 101,083 (New Position) | Filing |